No black box warning on record for Cresemba

As of the latest FDA labeling reviewed, Cresemba (ISAVUCONAZONIUM SULFATE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Cresemba medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Hepatic Adverse Drug Reactions: Serious hepatic reactions have been reported. Evaluate liver-related laboratory tests at the start and during the course of CRESEMBA therapy. ( 5.1 ) • Infusion-related reactions were reported during intravenous administration of CRESEMBA. Discontinue the infusion if these reactions occur. ( 5.2 ) • Hypersensitivity Reactions: Anaphylact

No black box warning on record for Cresemba

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Hepatic Adverse Drug Reactions: Serious hepatic reactions have been reported. Evaluate liver-related laboratory tests at the start and during the course of CRESEMBA therapy. ( 5.1 ) • Infusion-related reactions were reported during intravenous administration of CRESEMBA. Discontinue the infusion if these reactions occur. ( 5.2 ) • Hypersensitivity Reactions: Anaphylact

Cresemba Black Box Warning

No black box warning on record for Cresemba

Other warnings & precautions

Cresemba Black Box Warning

No black box warning on record for Cresemba

Other warnings & precautions